APA (7th ed.) Citation

C, B., MA, S., J, T., C, C., S, G., N, P., . . . AO, O. (2024). REverse transcriptase ACTivity (REACT) assay for point-of-care measurement of established and emerging antiretrovirals for HIV treatment and prevention. Analytical and bioanalytical chemistry, 416(29), 6809. https://doi.org/10.1007/s00216-024-05602-4

Chicago Style (17th ed.) Citation

C, Brainerd, Singh MA, Tatka J, Craig C, Gilligan-Steinberg S, Panpradist N, Chang MM, Lutz B, and Olanrewaju AO. "REverse Transcriptase ACTivity (REACT) Assay for Point-of-care Measurement of Established and Emerging Antiretrovirals for HIV Treatment and Prevention." Analytical and Bioanalytical Chemistry 416, no. 29 (2024): 6809. https://doi.org/10.1007/s00216-024-05602-4.

MLA (9th ed.) Citation

C, Brainerd, et al. "REverse Transcriptase ACTivity (REACT) Assay for Point-of-care Measurement of Established and Emerging Antiretrovirals for HIV Treatment and Prevention." Analytical and Bioanalytical Chemistry, vol. 416, no. 29, 2024, p. 6809, https://doi.org/10.1007/s00216-024-05602-4.